InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Sawhney Roger, Chief Financial Officer. Insider active across 1 companies, notably Omega Therapeutics, Inc.. Cumulatively, 2 filings have been published. Total volume traded: €84k. The latest transaction was filed on 3 August 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations2 total
€42,1222,941 shares@ €14.3225100.0% of flow
Common Stock
SEC:0000899243-21-031305·
Ideal exit: 30 Apr 2022 (T+270)
€42,1222,941 shares@ €14.322550.0% of flow
Common Stock
SEC:0000899243-21-031305:0·
Ideal exit: 30 Apr 2022 (T+270)
2 of 2 declarations
About Sawhney Roger
Roger Sawhney serves as the Chief Financial Officer of Omega Therapeutics, Inc. He is responsible for the company's financial management, including budgeting and financial analysis. His expertise contributes to informed decision-making to support the company's growth and innovation.
